Compare

NRC Health/$NRC

1D1W1M3M6MYTD1Y5YMAX

About NRC Health

NRC Health operates as a humanized healthcare and support organization. Its platform includes Listen, Understand, and Improve. The group provides solutions for Patient, Consumer, Employee, and Market experiences. The group's commitment to Human Understanding helps healthcare systems get to know the patients, families, consumers, employees, and communities it on a human level.
Ticker
$NRC
Sector
Health
Primary listing
NASDAQ
Employees
357

NRC Health Metrics

BasicAdvanced
$549M
96.48
$0.27
0.24
$0.64
2.47%

What the Analysts think about NRC Health

Analyst ratings (Buy, Hold, Sell) for NRC Health stock.
Analyst projections of the future price of NRC Health stock.

Bulls say / Bears say

Third-quarter revenue rose 11% to $38.4 million, net income increased to $4.7 million and free cash flow was $7.0 million. That is a much stronger result than the cash-flow performance in the previous quarter. (SEC)
Recurring contract value grew 9% to $154.1 million, and several long-standing customers renewed on multi-year agreements. That supports revenue visibility as new contracts convert into reported sales. (SEC)
NRC is developing AI tools around its long-running healthcare experience data, including features to help care teams capture and act on patient-rounding feedback. If customers adopt them, these tools could make the platform more useful and create room to sell more solutions to existing clients. (The Motley Fool)
Recurring contract value growth slowed to 9% in the third quarter from 11% in the second, and management said buyer uncertainty had paused some sales processes. Slower contract growth could weaken future revenue once current implementations roll through. (The Motley Fool, NRC Health)
For the first nine months, operating income fell 37% and operating cash flow fell 14% year on year, while selling, general and administrative costs rose 20%. That shows the strong third quarter has not yet reversed the broader pressure on earnings and cash generation. (StockTitan)
The company ended September with only $3.6 million of cash against roughly $103 million of loans. It also spent $16.7 million on share repurchases in the third quarter, which may limit financial flexibility if growth or cash generation falters. (StockTitan)
Data summarised monthly by Lightyear AI. Last updated on 5 Nov 2026.

NRC Health Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

NRC Health Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing NRC Health

Funds
Fund name
Fund size
$NRC weighting
SPDR Russell 2000 US Small Cap€R2US
$5.3B0.01%
SPDR Russell 2000 US Small Cap£R2SC
$5.3B0.01%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.